Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

Myrthe J. van Dijk, Minke A.E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J.M. Jans, Wouter W. van Solinge, Roger E.G. Schutgens, Richard van Wijk, Eduard J. Van Beers

Blood (2023) 142 (Supplement 1): 2515.

https://doi.org/10.1182/blood-2023-172829

Published: 2023

Journal Articles

A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

Suthesh Sivapalaratnam, Steve Austin, Ulrike Lorch, Thomas York, Andrew Want, Ashley Gosnell, Prafull S. Gandhi, Henrik Østergaard, Erik Bjornson, Tara O'Meara, Benny Sorensen, Roger E.G. Schutgens, Catherine Rea

Blood (2023) 142 (Supplement 1): 1225.

https://doi.org/10.1182/blood-2023-187279

Published: 2023

Journal Articles

Safety and Efficacy of Mitapivat (AG-348), an Oral Activator of Pyruvate Kinase R, in Subjects with Sickle Cell Disease: A Phase 2, Open-Label Study (ESTIMATE)

Myrthe J. van Dijk, Minke A.E. Rab, Anita W. Rijneveld, Erfan Nur, Marije Bartels, Judith J.M. Jans, Wouter W. van Solinge, Roger E.G. Schutgens, Richard van Wijk, Eduard J. Van Beers

Blood (2021) 138 (Supplement 1): 2047.

https://doi.org/10.1182/blood-2021-150234

Published: 2021

Journal Articles

Recombinant Porcine Factor VIII in Patients with Congenital Hemophilia a with Inhibitors Undergoing Surgery: Phase 3, Multicenter, Single Arm, Open-Label Study

Christian Pfrepper, Paolo Radossi, Jerzy Windyga, Kaan Kavakli, Roger E.G. Schutgens, Nazan Sarper, Jovanna Baptista, Kayode Badejo, Bruce Ewenstein, Nisha Jain

Blood (2021) 138 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2021-146179

Published: 2021

Journal Articles

Identification of Biomarkers That Are Associated with Clinical Complications of Hemoglobin SC Disease and Sickle Cell Anemia

Minke A.E. Rab, Celeste K. Kanne, Mitchel C. Berrevoets, Jennifer Bos, Brigitte A. van Oirschot, Erik Teske, Roger E.G. Schutgens, Gerard Pasterkamp, Richard van Wijk, Eduard J. Van Beers, Vivien A. Sheehan

Blood (2021) 138 (Supplement 1): 962.

https://doi.org/10.1182/blood-2021-145376

Published: 2021

Journal Articles

Interim Results from a Dose Escalating Study of AMT-060 (AAV5-hFIX) Gene Transfer in Adult Patients with Severe Hemophilia B

Frank W.G. Leebeek, MD PhD, Marco Tangelder, MD PhD, Karina Meijer, MD PhD, Giancarlo Castaman, Federica Cattaneo, MD, Michiel Coppens, MD PhD, Peter Kampmann, MD, Robert Klamroth, Roger E.G. Schutgens, MD PhD, Erhard Seifried, MD PhD, Joachim Schwaeble, MD, Halvard Boenig, MD PhD, Maaike Hendriks, Deya Corzo, MD FAAP, Wolfgang A. Miesbach, MD PhD

Blood (2016) 128 (22): 2314.

https://doi.org/10.1182/blood.V128.22.2314.2314

Published: 2016

Journal Articles

Clinical Joint Outcome after Joint Bleeds in Patients with Von Willebrand Disease Is Comparable to Moderate and Severe Hemophilia A Despite Fewer Joint Bleeds

Karin PM van Galen, MD, Merel Timmer, Mrs., Piet de Kleijn, Mr., Frank W.G. Leebeek, MD PhD, Roger E.G. Schutgens, MD PhD, Kathelijn Fischer, Eveline Mauser-Bunschoten

Blood (2016) 128 (22): 3789.

https://doi.org/10.1182/blood.V128.22.3789.3789

Published: 2016

Journal Articles

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Blood (2016) 128 (22): 207.

https://doi.org/10.1182/blood.V128.22.207.207

Published: 2016

Journal Articles

Renal Status and Hematuria in Older Patients with Hemophilia

Pal André Holme, PhDMD, Robert Campbell Tait, MD, Christophe Combescure, PhD, Erik Berntorp, MD PhD, Annarita Tagliaferri, Peter Staritz, MD, Roger E.G. Schutgens, MD PhD, Robert Klamroth, Natascha Marquardt, Stephan Rauchensteiner, Philippe De Moerloose, MD PhD

Blood (2015) 126 (23): 2290.

https://doi.org/10.1182/blood.V126.23.2290.2290

Published: 2015

Journal Articles

No Association Between Platelet Function and Hemophilia B Phenotype

Roger E.G. Schutgens, MD PhD, Esther R. van Bladel, MD PhD, Kathelijn Fischer, MD PhD MSC, Mark Roest, PhD, Rolf Urbanus, PhD

Blood (2014) 124 (21): 4994.

https://doi.org/10.1182/blood.V124.21.4994.4994

Published: 2014

Journal Articles

Interleukin-1β Is Essential for Blood-Induced Cartilage Damage I n Vitro

Lize F.D. van Vulpen, MD, Goris Roosendaal, MD PhD, Simon C. Mastbergen, PhD, Floris P.J.G. Lafeber, PhD, Roger E.G. Schutgens, MD PhD

Blood (2014) 124 (21): 240.

https://doi.org/10.1182/blood.V124.21.240.240

Published: 2014

Journal Articles

Out of Hospital Treatment of Acute Pulmonary Embolism in Patients with a Low NT-ProBNP Level.

Mariette J Agterof, MD, Roger E.G. Schutgens, MD, PhD, Repke J Snijder, MD, G. Epping, MD, Henny G Peltenburg, MD, PhD, Ward Posthuma, MD, PhD, J. A. Hardeman, MD, Rene Van der Griend, MD, PhD, Ted Koster, Martin Prins, MD, PhD, Douwe Biesma, MD, PhD

Blood (2009) 114 (22): 3996.

https://doi.org/10.1182/blood.V114.22.3996.3996

Published: 2009

Journal Articles

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

Marielle M.J. Beckers, MD, Roger E.G. Schutgens, MD, PhD, Martin H. Prins, MD, PhD, Douwe H. Biesma, MD, PhD

Blood (2005) 106 (11): 1623.

https://doi.org/10.1182/blood.V106.11.1623.1623

Published: 2005

NARROW

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

Safety and Efficacy of Mitapivat (AG-348), an Oral Activator of Pyruvate Kinase R, in Subjects with Sickle Cell Disease: A Phase 2, Open-Label Study (ESTIMATE)

Recombinant Porcine Factor VIII in Patients with Congenital Hemophilia a with Inhibitors Undergoing Surgery: Phase 3, Multicenter, Single Arm, Open-Label Study

Identification of Biomarkers That Are Associated with Clinical Complications of Hemoglobin SC Disease and Sickle Cell Anemia

Interim Results from a Dose Escalating Study of AMT-060 (AAV5-hFIX) Gene Transfer in Adult Patients with Severe Hemophilia B

Clinical Joint Outcome after Joint Bleeds in Patients with Von Willebrand Disease Is Comparable to Moderate and Severe Hemophilia A Despite Fewer Joint Bleeds

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Renal Status and Hematuria in Older Patients with Hemophilia

No Association Between Platelet Function and Hemophilia B Phenotype

Interleukin-1β Is Essential for Blood-Induced Cartilage Damage I n Vitro

Out of Hospital Treatment of Acute Pulmonary Embolism in Patients with a Low NT-ProBNP Level.

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only